Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients


Phase 1 Results N/A

Eligibility Criteria

Inclusion Criteria

- Computed tomography confirmed ischemic or hemorrhagic stroke
- Duration since stroke onset more than 3 and less than 12 months
- Age between 18 and 75 years old
- Persistent neurological deficits more than 4 points in NIHSS stroke scale
- Signed informed consent

Exclusion Criteria

- The history of previous stroke
- Seizures
- Thrombophilias or primary hematological diseases
- Malignancy
- Hepatic or renal dysfunctions
- Hemodynamic or respiratory instability
- Autoimmune disease
- HIV or uncontrolled bacterial, fungal, or viral infections
- Pregnancy
- Participation in other clinical trials